4.8 Article

Phosphorylation of β-arrestin2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs

Journal

ELIFE
Volume 6, Issue -, Pages -

Publisher

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.23777

Keywords

-

Categories

Funding

  1. Fondation pour la Recherche Medicale
  2. Agence Nationale de la Recherche [ANR-2011-1619 01]
  3. Centre National de la Recherche Scientifique
  4. Institut National de la Sante et de la Recherche Medicale
  5. Universite de Montpellier
  6. Institut National de la Recherche Agronomique
  7. Universite Francois-Rabelais

Ask authors/readers for more resources

In addition to their role in desensitization and internalization of G protein-coupled receptors (GPCRs),beta-arrestins are essential scaffolds linking GPCRs to Erk1/2 signaling. However, their role in GPCR-operated Erk1/2 activation differs between GPCRs and the underlying mechanism remains poorly characterized. Here, we show that activation of serotonin 5-HT2C receptors, which engage Erk1/2 pathway via a beta-arrestin-dependent mechanism, promotes MEK-dependent beta-arrestin2 phosphorylation at Thr(383), a necessary step for Erk recruitment to the receptor/beta-arrestin complex and Erk activation. Likewise, Thr(383) phosphorylation is involved in beta-arrestin-dependent Erk1/2 stimulation elicited by other GPCRs such as beta(2)-adrenergic, FSH and CXCR4 receptors, but does not affect the beta-arrestin-independent Erk1/2 activation by 5-HT4 receptor. Collectively, these data show that beta-arrestin2 phosphorylation at Thr(383) underlies beta-arrestin-dependent Erk1/2 activation by GPCRs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available